Android app on Google Play

Canaccord Genuity Positive on GenMark Diagnostics (GNMK)

January 15, 2013 11:53 AM EST Send to a Friend
Get Alerts GNMK Hot Sheet
Price: $9.10 +0.44%

Rating Summary:
    4 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 10 | New: 7
Trade GNMK Now!
Join SI Premium – FREE
Canaccord Genuity today reiterated a Buy rating on GenMark Diagnostics (NASDAQ: GNMK) and raised its price target to $14.00 (from $12.00).

"Given management's recent track record of executing, coupled with its long-term growth trajectory, we believe GNMK merits trading at the upper end of the MDx peer group P/S multiple (5x-7x)," said analyst Jeffrey Frelick.

With a strong start to the flu season, Frelick thinks GNMK should see good results from its RVP test.

For an analyst ratings summary and ratings history on GenMark Diagnostics (NASDAQ: GNMK) click here. For more ratings news on GenMark Diagnostics click here.

Shares of GenMark Diagnostics closed at $11.14 yesterday.




You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Canaccord Genuity

Add Your Comment